NCT04768686 - FLX475 Combined With Pembrolizumab in Patients With Advanced or Metastatic Gastric Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 18, 2021

Primary Completion Date

August 12, 2024

Study Completion Date

August 12, 2024

Conditions

Gastric Cancer

Interventions

DRUG

FLX475

tablet

DRUG

Pembrolizumab

IV infusion

Trial Locations (10)

Hanllym University Medical Center, Anyang-si

Seoul National University Bundang Hospital, Seongnam-si

The Catholic University of Korea St. Vincent Hospital, Suwon

Chonnam National University Hwasun Hospital, Hwasun

Asan Medical Center, Seoul

Gangnam Severance Hospital, Seoul

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

Severance Hospital, Seoul